Immunotherapy treatment enhances lymphoma survival, landmark study
November 4, 2024
4:27 am
Description:
The Phase III findings give evidence for the immunothe-rapy treatment regimen to become standard of care for advanced Hodgkin lymphoma.
Get started with CRSC for Clinical Training
No matter whether auditing against your protocols, standard operating procedures, industry specifications, or regulations, CRSC has experience in three primary sides of compliance:
